Medikinet MR 5 mg modified-release capsules, hard
Each modified-release capsule, hard contains 5 mg methylphenidate hydrochloride, equivalent to 4,35 mg methylphenidate.
Medikinet MR 10 mg modified-release capsules, hard
Each modified-release capsule, hard contains 10 mg methylphenidate hydrochloride, equivalent to 8,65 mg methylphenidate.
Medikinet MR 20 mg modified-release capsules, hard
Each modified-release capsule, hard contains 20 mg methylphenidate hydrochloride, equivalent to 17,30 mg methylphenidate.
Medikinet MR 30 mg modified-release capsules, hard
Each modified-release capsule, hard contains 30 mg methylphenidate hydrochloride, equivalent to 25,95 mg methylphenidate.
Medikinet MR 40 mg modified-release capsules, hard
Each modified-release capsule, hard contains 40 mg methylphenidate hydrochloride, equivalent to 34,60 mg methylphenidate.
Medikinet MR 50 mg modified-release capsules, hard
Each modified-release capsule, hard contains 50 mg methylphenidate hydrochloride, equivalent to 43,25 mg methylphenidate.
Medikinet MR 60 mg modified-release capsules, hard
Each modified-release capsule, hard contains 60 mg methylphenidate hydrochloride, equivalent to 51,90 mg methylphenidate.
Pharmacotherapeutic group: psychoanaleptics (A.1.2): psychostimulants, agents used for ADHD and nootropics; centrally acting sympathomimetics
What it is used for
MEDIKINET MR is used to treat ‘attention deficit hyperactivity disorder’ (ADHD).
- it is used in children aged 6 years and over and in adults who had ADHD onset in childhood.
- it is used only after other treatments which do not involve medication have been tried and have been insufficient. e.g. counselling and behavioural therapy.
MEDIKINET MR is not for use as a treatment for ADHD in children under 6 years of age.
How it works
MEDIKINET MR improves the activity of certain parts of the brain which are under-active. The medicine can help improve attention span and concentration and reduce impulsive behaviour. The medicine is given as part of a treatment programme, which usually includes psychological, educational and social therapy. MEDIKINET MR treatment must only be initiated by, and used under the supervision of a doctor, specialised in the treatment of ADHD, such as an expert paediatrician, a child and adolescent psychiatrist or a psychiatrist. A careful examination by this doctor is required. If you as an adult have not been treated before, the doctor will perform tests to confirm that you have been affected by ADHD since childhood. Although there is no cure for ADHD, it can be managed using treatment programmes.
About ADHD
Children and young people with ADHD find it:
- hard to sit still and
- hard to concentrate.
It is not their fault that they cannot do these things.
Patients can have ADHD in varying degrees with symptoms including:
- lack of concentration
- restlessness
- hyperactivity
- impulsivity
- emotional instability
- disorganised thinking
This is shown by, for example:
- difficulty concentrating
- forgetfulness
- talking too much
- difficulties in planning and carrying out tasks to completion
- blindfold actions
- impatience
ADHD does not affect the intelligence of a child or young person.